(Q36473648)

14 August 2017

1 reference

title

Toward a core nutraceutical program for cancer management (English)

1 reference

14 August 2017

1 reference

2

Keith I Block

1 reference

14 August 2017

Mark F McCarty

1

1 reference

14 August 2017

publication date

1 June 2006

1 reference

Integrative Cancer Therapies

14 August 2017

published in

1 reference

14 August 2017

volume

5

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

150-171

1 reference

A wholly nutritional 'multifocal angiostatic therapy' for control of disseminated cancer

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Multifocal angiostatic therapy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Galectin-3 and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Galectin-3 induces endothelial cell morphogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

On the role of galectin-3 in cancer apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Nuclear factor-kappaB: the enemy within

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Tumor cell adhesion to endothelial cells is increased by endotoxin via an upregulation of beta-1 integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Gold compounds inhibit adhesion of human cancer cells to vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Signaling pathways responsible for cancer cell invasion as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Natural killer cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Natural history of HLA expression during tumour development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Effect of palm oil carotene on breast cancer tumorigenicity in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Potentiation of cytotoxic activity in naïve and tumor-bearing mice by oral administration of hot-water extracts from Agaricus brazei fruiting bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

IL-12 Production Induced by Agaricus blazei Fraction H (ABH) Involves Toll-like Receptor (TLR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Immuno-potentiating effects of the antler-shaped fruiting body of Ganoderma lucidum (Rokkaku-Reishi).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

An in vivo study of hepatic and splenic interleukin-1 beta mRNA expression following oral PSK or LEM administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Immune receptors for polysaccharides from Ganoderma lucidum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Effects of a mushroom mycelium extract on the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Harry M. Vars Research Award. Glutamine enhances immunoregulation of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Effect of glutamine on the initiation and promotion phases of DMBA‐induced mammary tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Prostaglandin E2 Suppresses NK Activity In Vivo and Promotes Postoperative Tumor Metastasis in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Cyclooxygenase inhibitors modulate NK activities that control metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Involvement of Nuclear Factor-κB in the Inhibition of Interleukin-12 Production from Mouse Macrophages by Baicalein, a Flavonoid inScutellaria baicalensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Inhibition of interleukin-12 production in mouse macrophages via decreased nuclear factor-kappaB DNA binding activity by myricetin, a naturally occurring flavonoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The NF-kappaB binding site is essential for transcriptional activation of the IL-15 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Thrombosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Tissue factor and fibrin in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Selenium and immune cell functions. II. Effect on lymphocyte-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

ABC of palliative care. Anorexia, cachexia, and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Induction of muscle protein degradation by a tumour factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

21 January 2018

Tumor-host interactions

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The relationship between a urinary cachectic factor and weight loss in advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Signalling pathways in the induction of proteasome expression by proteolysis-inducing factor in murine myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Nutritional supplementation of the leucine metabolite beta-hydroxy-beta-methylbutyrate (hmb) during resistance training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Pharmacological interference with tissue hypercatabolism in tumour-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Antiproliferative activity of flavonoids on several cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Control of protein synthesis by amino acid availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Growth hormone together with glutamine-containing total parenteral nutrition maintains muscle glutamine levels and results in a less negative nitrogen balance after surgical trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Effect of glutamine supplementation of the diet on tissue protein synthesis rate of glucocorticoid-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Glutamine supplementation in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Insulin-like growth factor-I in muscle metabolism and myotherapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Molecular signaling pathways regulating muscle proteolysis during atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The insulin-like growth factor system and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Evidence for a link between IGF-I and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The insulin-like growth factor-I receptor as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Prevention of Cancer Through Lifestyle Changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Intensive lifestyle changes may affect the progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Pathogenesis of increased risk of thrombosis in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Thrombin induces neoangiogenesis in the chick chorioallantoic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Thrombin receptor expression is upregulated in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Transcriptional regulation of tissue factor expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Hypoxia-associated induction of early growth response-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Oxygen-regulated transcription factors and their role in pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Selective protein kinase C inhibitors and their applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis Cleaves and inactivates plasminogen activator inhibitor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Weight loss reduces tissue factor in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Plasma levels of tissue factor antigen in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Hypercoagulability in the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Hypercalcemia of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

PTHrP gene expression in cancer: do all paths lead to Ets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Current insights into the role of transforming growth factor-beta in bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The noncalcemic vitamin D analogues EB1089 and 22-oxacalcitriol interact with the vitamin D receptor and suppress parathyroid hormone-related peptide gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Parathyroid hormone-related protein in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Protective role of n-3 lipids and soy protein in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Effect of omega 3 polyunsaturated fatty acid ingestion on bone metabolism and osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

HMG-CoA reductase inhibitors and the risk of vertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Statin lipid-lowering drugs and bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The argument for increasing selenium intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Folic acid and homocysteine in age-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Folate: a key to optimizing health and reducing disease risk in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Vitamin D in preventive medicine: are we ignoring the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Failure of vitamin E in clinical trials: is gamma-tocopherol the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Vitamin K and bone health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Low magnesium and atherosclerosis: an evidence-based link.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Role of chromium in human health and in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Nutritional and clinical relevance of lutein in human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Point of view--a role for "nutritional insurance" supplementation in preventive medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

25-hydroxyvitamin D3-1alpha-hydroxylase expression in normal and malignant human colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Autocrine metabolism of vitamin D in normal and malignant breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Antiproliferative role of vitamin D and its analogs--a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Solar radiation, vitamin D and survival rate of colon cancer in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The association between magnesium intake and fasting insulin concentration in healthy middle-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Magnesium deficiency is associated with insulin resistance in obese children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

A prospective study of plasma C-peptide and colorectal cancer risk in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Monomethyl selenium--specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The association of diet and thrombotic risk factors in healthy male vegetarians and meat-eaters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Sub-optimal taurine status may promote platelet hyperaggregability in vegetarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

The anti-angiogenic basis of metronomic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Platelet-derived growth factor receptors: a therapeutic target in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Diet and body mass index in 38 000 EPIC-Oxford meat-eaters, fish-eaters, vegetarians and vegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735406288443

21 January 2018

Identifiers

DOI

10.1177/1534735406288443

1 reference

14 August 2017

1 reference